News

Filter

Current filters:

TransgenePharmaceutical

Sanofi and Transgene collaborate on immunotherapy treatments; NAS designation of Aubagio disputed

25-03-2013

Drug major Sanofi (Euronext: SAN) and fellow France-based biotech firm Transgene SA (NYSE-Euronext: TNG)…

AubagioBiotechnologyEuropeGenzymeImmunologicalsNeurologicalPharmaceuticalProductionRegulationSanofiTransgene

Transgene to seek partner for HCV vaccine TG4040 on strong Ph II results

09-11-2011

French biotech firm Transgene (Euronext Paris: FR0005175080) has revealed interim data showing a substantial…

BiotechnologyLicensingOncologyPharmaceuticalResearchTransgeneVaccines

Transgene, ChronTech Pharma and Inovio to collaborate on hep C vaccine

21-04-2011

France’s Transgene (Euronext Paris: FR0005175080) has signed a collaboration agreement with Sweden’s…

Anti-viralsChronTech PharmaInovio PharmaceuticalsPharmaceuticalResearchTransgeneVaccines

Roche pulls out of Papilloma virus deal with Transgene

24-02-2011

Swiss drug major Roche (SIX: ROG) has terminated its 2007 agreement under which France’s Transgene…

Anti-viralsLicensingPharmaceuticalResearchRocheTransgeneVaccines

Transgene in companion diagnostic deal with Beckman to select patients for TG4010

06-01-2011

French biotech firm Transgene (Euronext: TNG) yesterday signed an agreement with USA-based Beckman Coulter…

Beckman CoulterBiotechnologyLicensingNovartisOncologyPharmaceuticalTransgene

Jennerex licenses lead cancer compound to Transgene in over $116 million deal

09-09-2010

US privately-held oncology-focussed drug developer Jennerex has entered into an exclusive partnership…

JennerexLicensingOncologyPharmaceuticalTransgene

France’s Transgene confirms fund raising of up to 150 million euros

25-03-2010

Following press speculation that the French biopharmaceutical group was looking to increase its financial…

BiotechnologyFinancialPharmaceuticalTransgene

Back to top